Discover a study that analysed evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms. Learn ...

A new subgroup analysis reveals that adolescents with moderate-to-severe plaque psoriasis treated with once-daily icotrokinra ...

Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in high-impact areas.

However, this new study, led by researcher Hye Sun Gwak, reviewed data from 13 different studies and found that some of these ...